Amar Sawhney News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Instylla Completes Enrollment of Landmark Hypervascular Tumor Pivotal Study

Instylla Completes Enrollment of Landmark Hypervascular Tumor Pivotal Study
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesAmar sawhneyNadine abi jaoudehPrnewswire instylla incInstylla incNational principal investigatorUniversity of californiaTumor pivotalTumor pivotal studyHydrogel embolic systemInterventional radiologyManaging directorEmbrace hydrogel embolic system

Pramand Launches CraniSeal™ Dural Sealant to Give Surgeons a New Option for Dural Repair

Pramand Launches CraniSeal™ Dural Sealant to Give Surgeons a New Option for Dural Repair
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Amar sawhneyDural sealantSeal dural sealantPre market approvalNeurosurgical focus

Pramand Launches CraniSeal™ Dural Sealant to Give Surgeons a New Option for Dural Repair

Pramand Launches CraniSeal™ Dural Sealant to Give Surgeons a New Option for Dural Repair
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Amar sawhneyDural sealantSeal dural sealantPre market approvalNeurosurgical focus

Instylla Closes $30M Equity Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Henry chenAmar sawhneySparta groupCatalyst health venturesInstylla incDelos capitalExcelestar venturesAscension venturesAmed venturesManaging partnerInstylla boardTumor pivotal studyInstylla hydrogel embolic system

Instylla Announces Completion of $30MM EQUITY Financing

/PRNewswire/ Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the.

United statesAmar sawhneyHenry chenPrnewswire instylla incSparta groupInstylla incCatalyst health venturesDelos capitalExcelestar venturesAscension venturesAmed venturesNorth americaManaging directorTumor pivotal studyInstylla hydrogel embolic systemManaging partner